MLchartDataset catalogue

anti-IGF1R recombinant monoclonal antibody MK-0646

Term · Oncology and biomedicine · MLC-T-ONC-000623

A substance being studied in the treatment of many types of cancer. Anti-IGF1R recombinant monoclonal antibody MK-0646 binds to a protein called insulin-like growth factor receptor (IGFR) on the surface of cells. This may prevent the cells from growing when IGF is present. It may also kill cancer cells. Anti-IGF1R recombinant monoclonal antibody MK-0646 is a type of monoclonal antibody. Also called MK-0646.

Table 1. Record
IdentifierMLC-T-ONC-000623
FieldOncology and biomedicine
SynonymsMK-0646
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000623",
  "term": "anti-IGF1R recombinant monoclonal antibody MK-0646",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of many types of cancer. Anti-IGF1R recombinant monoclonal antibody MK-0646 binds to a protein called insulin-like growth factor receptor (IGFR) on the surface of cells. This may prevent the cells from growing when IGF is present. It may also kill cancer cells. Anti-IGF1R recombinant monoclonal antibody MK-0646 is a type of monoclonal antibody. Also called MK-0646.",
  "synonyms": [
    "MK-0646"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-igf1r-recombinant-monoclonal-antibody-mk-0646/"
}

Record 1,920 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.